INVA vs SPG · P/E 3.6, rev $217.6M vs rev $3.55B
Innoviva Inc (INVA) versus SPG (SPG) — a side-by-side from cached financials, not a winner call.
Innoviva Inc (INVA) is a biotechnology company listed on US.
SPG (SPG) common stock.
Latest reported INVA revenue for 2026-06-30 was $217.6M. Net income was $103.2M. INVA currently screens at market cap $1.66B and trailing P/E 3.6.
Latest reported SPG revenue for 2026-06-30 was $3.55B. Net income was $1.14B. SPG currently screens at market cap $0.
INVA currently screens at market cap $1.66B and trailing P/E 3.6. SPG currently screens at market cap $0.
Not investment advice. Open the INVA and SPG stock pages for the full models.
Not investment advice.